Breaking News Instant updates and real-time market news.

VIA

Viacom

$35.50

0.2 (0.57%)

, VIAB

Viacom

$30.90

0.13 (0.42%)

06:00
04/09/18
04/09
06:00
04/09/18
06:00

Viacom asks CBS to sweeten merger bid by about $2.8B, Reuters reports

Viacom (VIAB) has asked CBS (CBS) to raise its merger offer by almost a quarter, or around $2.8B, Reuters reports, citing people familiar with the matter. CBS is now considering its next steps in the deal negotiations, the sources say. Reference Link

VIA

Viacom

$35.50

0.2 (0.57%)

VIAB

Viacom

$30.90

0.13 (0.42%)

CBS

CBS

$52.84

-0.04 (-0.08%)

CBS.A

$53.13

-0.01 (-0.02%)

  • 12

    Apr

  • 03

    May

VIA Viacom
$35.50

0.2 (0.57%)

03/28/18
SBSH
03/28/18
UPGRADE
Target $30
SBSH
Neutral
Viacom upgraded to Neutral from Sell at Citi
Citi analyst Jason Bazinet upgraded Viacom (VIAB) to Neutral and raised his price target for the shares to $30 from $26. The analyst assigns a 50% probability of a merger with CBS (CBS) and believes Viacom shares would be worth $30 under such a scenario.
02/28/18
02/28/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Viacom (VIA, VIAB) upgraded to Neutral from Underperform at Macquarie by analyst Tim Nollen, who told investors that the company has taken a decisive turn in strategy to re-set its distribution relationships and is in the early stages of a turnaround. Nollen believes Viacom can return to growth despite any merger outcome with CBS (CBS) and raised estimates on increased U.S. ad and affiliate revenue growth. 2. Tenet (THC) upgraded to Outperform from Market Perform at Raymond James by analyst John Ransom to reflect management's efforts to reduce costs and sell assets. Ransom said the company is reducing debt and could generate $400M in annual free cash flow until its NOL runs out. 3. AB InBev (BUD) upgraded to Positive from Neutral at Susquehanna by analyst Pablo Zuanic, who said the recent weakness provided an attractive entry point as the company had a great January to September period of organic growth, he sees deal synergies with SAB, and he believes Q4 was just as good if not better than the same period a year ago. 4. Etsy (ETSY) upgraded to Buy at Roth Capital by analyst Darren Aftahi after a "strong" Q4 and citing growth reacceleration and margin expansion. 5. Verizon (VZ) upgraded to Buy from Neutral at MoffettNathanson. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/16/18
BNCH
02/16/18
NO CHANGE
Target $86
BNCH
Buy
CBS price target raised to $86 from $78 at Benchmark
Benchmark analyst Daniel Kurnos raised his FY18 revenue forecast for CBS (CBS) by $750M to $14.9B after the company's Q4 report to reflect a healthier ad environment and increased his price target to $86 from $78. While "everyone continues to denigrate" a Viacom (VIAB) merger, Kurnos point outs the international distribution benefits that don't seem to be factored into the equation. The analyst, who thinks CBS shares are "a bargain," keeps a Buy rating on the stock.
02/12/18
BRRR
02/12/18
NO CHANGE
BRRR
Potential reunion with CBS looms over Viacom fundamentals, says Barrington
Barrington analyst James Goss noted that Viacom (VIAB), which reported Q1 earnings last Thursday, beat the firm's EPS estimate, but fell 4% short of its revenue estimate, mainly due to a larger-than-expected decline in the revenue rate for Paramount. Godd reiterated a Market Perform rating on Viacom, saying that while the company's strategy will push it in a favorable direction, in the near term the primary catalyst appears to be the chance to recombine with CBS (CBS).
VIAB Viacom
$30.90

0.13 (0.42%)

04/03/18
KEYB
04/03/18
NO CHANGE
KEYB
Sector Weight
KeyBanc would likely view Viacom acquisition by CBS favorably
KeyBanc analyst Andy Hargreaves notes that news reports suggest an all-stock offer for Viacom (VIAB) by CBS (CBS) is imminent. The analyst believes this would create earnings growth potential through cost synergies in excess of what CBS standalone is capable of and could increase the likelihood of monetizing Viacom-owned assets through disposition. Hargreaves views the near-term risk/reward on CBS as positive and would likely view a deal favorably. He reiterates a Sector Weight rating on CBS shares.
04/03/18
LOOP
04/03/18
NO CHANGE
Target $75
LOOP
Buy
CBS take-under offer for Viacom may 'uncouple' the stocks, says Loop Capital
Loop Capital analyst Alan Gould is keeping his Buy rating and $75 price target on CBS (CBS) following yesterday's afterhours reports of a take-under consideration for Viacom (VIAB). The analyst notes that the two stocks have been linked in underperformance, and that the low offer may uncouple that momentum. Gould adds that the deal could give CBS greater scale, allow an opportunity to buy the company early in its turnaround process, and add to its distribution leverage with scale and synergies.
03/28/18
SBSH
03/28/18
NO CHANGE
SBSH
Citi sees 50/50 chance of CBS, Viacom merger
Amid media reports that CBS (CBS) and Viacom (VIAB) are discussing a combination, Citi analyst Jason Bazinet is out with a research note ascribing a 50/50 chance of a deal being reached. The analyst sees three unknowns: will they merge, will CBS pay a premium for Viacom, and how large are the synergies? To reflect the potential for a deal, Bazinet upgraded Viacom to Neutral from Sell and raised his price target for the shares to $30 from $26. The analyst also lowered his price target for Buy-rated CBS to $61 from $71.
CBS CBS
$52.84

-0.04 (-0.08%)

CBS.A
$53.13

-0.01 (-0.02%)

TODAY'S FREE FLY STORIES

FB

Facebook

$159.69

0.03 (0.02%)

05:28
04/26/18
04/26
05:28
04/26/18
05:28
Recommendations
Facebook analyst commentary  »

Facebook's strong Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WELL

Welltower

$50.45

-0.57 (-1.12%)

, QCP

Quality Care Properties

$22.72

1.92 (9.23%)

05:25
04/26/18
04/26
05:25
04/26/18
05:25
Hot Stocks
Breaking Hot Stocks news story on Welltower, Quality Care Properties »

Welltower to acquire…

WELL

Welltower

$50.45

-0.57 (-1.12%)

QCP

Quality Care Properties

$22.72

1.92 (9.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 03

    May

  • 04

    May

ANTM

Anthem

$238.81

13.73 (6.10%)

05:22
04/26/18
04/26
05:22
04/26/18
05:22
Upgrade
Anthem rating change  »

Anthem upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$159.69

0.03 (0.02%)

05:20
04/26/18
04/26
05:20
04/26/18
05:20
Recommendations
Facebook analyst commentary  »

Facebook price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERN

Erin Energy

$1.65

-0.825 (-33.33%)

05:18
04/26/18
04/26
05:18
04/26/18
05:18
Hot Stocks
Erin Energy files voluntary petitions under Chapter 11 to pursue reorganization »

Erin Energy and certain…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTXS

Citrix

$96.54

0.04 (0.04%)

05:16
04/26/18
04/26
05:16
04/26/18
05:16
Recommendations
Citrix analyst commentary  »

Citrix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 08

    May

  • 09

    May

AMD

AMD

$9.72

-0.37 (-3.67%)

05:13
04/26/18
04/26
05:13
04/26/18
05:13
Recommendations
AMD analyst commentary  »

AMD could see…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

EBAY

eBay

$40.98

-0.2 (-0.49%)

05:09
04/26/18
04/26
05:09
04/26/18
05:09
Recommendations
eBay analyst commentary  »

eBay GMV growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRVG

Trivago

$4.71

-1.65 (-25.94%)

05:01
04/26/18
04/26
05:01
04/26/18
05:01
Downgrade
Trivago rating change  »

Trivago downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPR

HighPoint Resources

$6.65

0.14 (2.15%)

04:58
04/26/18
04/26
04:58
04/26/18
04:58
Initiation
HighPoint Resources initiated  »

HighPoint Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

AVY

Avery Dennison

$106.68

1.195 (1.13%)

04:57
04/26/18
04/26
04:57
04/26/18
04:57
Upgrade
Avery Dennison rating change  »

Avery Dennison upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Jobless Claims to be reported at 08:30 »

Week of 4/21 Jobless…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Breaking General news story  »

Week of 4/25 Fed Balance…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Durable Goods Orders to be reported at 08:30 »

March Durable Goods…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Durable Goods Orders Ex-transportation to be reported at 08:30 »

March Durable Goods…

WYN

Wyndham

$117.67

1.83 (1.58%)

, LQ

La Quinta

$19.70

0.08 (0.41%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
La Quinta to host special shareholder meeting »

Special Shareholder…

WYN

Wyndham

$117.67

1.83 (1.58%)

LQ

La Quinta

$19.70

0.08 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 02

    May

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Wholesale Inventories [Advance] M/M % hange to be reported at 08:30 »

March Wholesale…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
International Trade in Goods Balance to be reported at 08:30 »

March International Trade…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Breaking General news story  »

Week of 4/16 Money Supply…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Breaking General news story  »

6-Month Bill Announcement…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Breaking General news story  »

Week of 4/20 EIA Natural…

SMMT

Summit Therapeutics

$13.66

0.13 (0.96%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
Summit Therapeutics management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

ABBV

AbbVie

$91.91

0.57 (0.62%)

, ACOR

Acorda Therapeutics

$22.95

-0.15 (-0.65%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
American Academy of Neurology to hold annual meeting »

2018 Annual Meeting of…

ABBV

AbbVie

$91.91

0.57 (0.62%)

ACOR

Acorda Therapeutics

$22.95

-0.15 (-0.65%)

ALXN

Alexion

$106.07

-0.37 (-0.35%)

AKCA

Akcea Therapeutics

$26.85

0.02 (0.07%)

RHHBY

Roche

TEVA

Teva

$17.27

-0.28 (-1.60%)

UBS

UBS

$16.78

-0.095 (-0.56%)

MDT

Medtronic

$79.47

0.12 (0.15%)

MCK

McKesson

$151.70

2.76 (1.85%)

NVTA

Invitae

$5.53

-0.15 (-2.64%)

IONS

Ionis Pharmaceuticals

$43.98

-1.35 (-2.98%)

IPXL

Impax

$19.25

-0.65 (-3.27%)

DNA

Bought by RHHBY

DGX

Quest Diagnostics

$101.17

1.42 (1.42%)

ESALY

Eisai

DEPO

Depomed

$6.66

-0.17 (-2.49%)

CPRX

Catalyst Pharmaceuticals

$2.64

0.04 (1.54%)

BSX

Boston Scientific

$29.44

1.01 (3.55%)

BMRN

BioMarin

$81.41

0.33 (0.41%)

MYL

Mylan

$38.93

-1.32 (-3.28%)

NBIX

Neurocrine

$78.13

-0.3 (-0.38%)

NVS

Novartis

$76.42

-0.58 (-0.75%)

PFE

Pfizer

$36.69

-0.36 (-0.97%)

RARX

RA Pharmaceuticals

$5.76

-0.2 (-3.36%)

SNY

Sanofi

$40.11

0.335 (0.84%)

SYK

Stryker

$165.44

0.77 (0.47%)

SUPN

Supernus

$47.30

0.55 (1.18%)

LLY

Eli Lilly

$81.17

1.08 (1.35%)

BAYRY

Bayer

AMGN

Amgen

$174.83

2.92 (1.70%)

ALNY

Alnylam

$94.35

-0.34 (-0.36%)

BIIB

Biogen

$269.47

7.45 (2.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 27

    Apr

  • 27

    Apr

  • 28

    Apr

  • 30

    Apr

  • 30

    Apr

  • 01

    May

  • 02

    May

  • 02

    May

  • 03

    May

  • 04

    May

  • 07

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 09

    May

  • 10

    May

  • 17

    May

  • 18

    May

  • 21

    May

  • 21

    May

  • 22

    May

  • 23

    May

  • 23

    May

  • 25

    May

  • 28

    May

  • 30

    May

  • 05

    Jun

  • 07

    Jun

  • 07

    Jun

  • 12

    Jun

  • 12

    Jun

  • 16

    Jun

  • 06

    Jul

  • 11

    Aug

  • 12

    Sep

  • 05

    Oct

  • 20

    Oct

  • 13

    Nov

  • 28

    Jan

SCPH

scPharmaceuticals

$9.92

-0.1 (-1.00%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
scPharmaceuticals management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 23

    Jun

ALNA

Allena Pharmaceuticals

$14.77

0.845 (6.07%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
Allena Pharmaceuticals management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.